Cite
APA Citation
Kim, B. H., Yu, S. J., Kang, W., Cho, S. B., Park, S. Y., Kim, S. U., & Kim, D. Y. (2022). expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma. Journal of gastroenterology and hepatology, 37(3), 428–439. http://access.bl.uk/ark:/81055/vdc_100152629377.0x00003c